PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma
2024 · Cancer Research · 28 citations
https://doi.org/10.1158/0008-5472.can-23-2521
Y
Yinghan Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
53
Citations
3
h-index
2
i10-index
Yinghan Wang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Ferroptosis and cancer prognosis & Tryptophan and brain disorders & HIV-related health complications and treatments. The author has an h-index of 3, co-authored 18 publications.
ORCID: 0000-0002-3737-3535Papers by this author
worksThe Potential of PARP Inhibitors as Antitumor Drugs and the Perspective of Molecular Design
2024 · Journal of Medicinal Chemistry · 13 citations
https://doi.org/10.1021/acs.jmedchem.4c02642
Supplementary Data from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25826490.v1
Supplementary Data 1 from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25826502.v1
Supplementary Data 3 from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25826493
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat